The Lancet Digital Health
-
1
[Comment] The optimal vascular access for haemodialysis remains elusive
-
2
[Articles] Bioengineered acellular tissue engineered vessels versus autogenous fistulae for haemodialysis access: a multicentre, randomised, controlled, phase 3 trial
-
3
[Editorial] Oculomics and the search for brain biomarkers
-
4
[Viewpoint] Beyond language: generative artificial intelligence as a general computing model for medicine
-
5
[Review] Artificial intelligence–based retinal imaging for brain health assessment: a scoping review
-
6
[Viewpoint] Equity in virtual urgent care: lessons from health system-based models
-
7
[Comment] Deception in clinical large language models: an under-recognised safety risk
-
8
[Correspondence] Extending responsible artificial intelligence to palliative care: the irreversibility problem with algorithmic accountability
-
9
[Correspondence] Reproductive health data must be part of the UK's Health Data Research Service
-
10
[Articles] Effectiveness of app-based interventions for glucose management, cardiometabolic and mental health, and related risk factors: an umbrella review with meta-analysis
The Lancet Gastroenterology & Hepatology
-
1
[Editorial] Blood-based CRC screening: closer, but not there yet
-
2
[Correspondence] Liver stiffness dynamics in European populations
-
3
[Editorial] Cyclosporiasis and CDC cuts: the perfect storm
-
4
[Correspondence] From viral clearance to cancer prevention: the next phase of hepatitis elimination
-
5
[Correspondence] Liver stiffness dynamics in European populations – Authors’ reply
-
6
[Corrections] Correction to Lancet Gastroenterol Hepatol 2026; 11: 627–44
-
7
[Comment] Propelling MASLD trials into the era of non-invasive tests
-
8
[Review] Bowel endometriosis: from pathogenesis to clinical management
-
9
[Review] Barrier restoration as a therapeutic strategy for disorders of gut–brain interaction
-
10
[Articles] Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label, randomised controlled superiority trial
The Lancet Global Health
-
1
[Editorial] Small island developing states on the frontline
-
2
[Corrections] Correction to Lancet Glob Health 2026; 14: e702-13
-
3
[Viewpoint] Global health ethics in international collaborative research during policy transition: what can we learn from the proposed newborn hepatitis B vaccine trial in Guinea-Bissau?
-
4
[Comment] Peripheral arterial disease: beyond prevalence estimates to equitable care
-
5
[Articles] Global feasibility of cervical cancer elimination: a multidimensional scenario-based modelling analysis across 175 countries
-
6
[Articles] Phone-based screening versus home-based screening after tuberculosis in India (TB Aftermath): a multicentre, open-label, randomised, controlled, non-inferiority trial
-
7
[Comment] Country ownership without fiscal justice is responsibility without resources
-
8
[Articles] In-hospital and post-discharge mortality among infants with respiratory syncytial virus in rural Kenya: a 25-year retrospective cohort study
-
9
[Articles] Genetic testing versus clinical screening for relatives of patients with hypertrophic cardiomyopathy in the Brazilian public health system: a cost-utility analysis
-
10
[Countdown] The 2025 small island developing states report of the Lancet Countdown on health and climate change: building resilience in the face of rising heat
The Lancet Haematology
-
1
[In Focus] Reproductive health in Ireland: moving forward as others roll back
-
2
[In Focus] Living with a bleeding disorder as a woman
-
3
[In Focus] Menstruation in Nepal: tradition, stigma, and transition
-
4
[Articles] Haematopoietic stem cell transplantation in hepatosplenic T-cell lymphoma: a retrospective analysis of the EBMT Lymphoma Working Party
-
5
[Editorial] Beyond maximum grade: a decade in the making
-
6
[Comment] Beyond maximum grade: making toxicity count
-
7
[Correspondence] FAIR(er) treatment of non-anaemic iron deficiency during pregnancy: clarifying the evidence – Authors' reply
-
8
[News] ISTH 2026 Congress
-
9
[Articles] Epcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2): an open-label, multicentre, phase 1/2 b trial
-
10
[News] Building stronger blood systems
The Lancet Healthy Longevity
-
1
[Editorial] Ending preventable heat-related deaths among older adults
-
2
[Personal View] Falls resilience framework: advancing from risk reduction to resilience building in older adults
-
3
[Comment] Adjunctive metformin for obesity and frailty in older people—puncturing inflated expectations?
-
4
[Articles] Metformin added to lifestyle intervention for physical function in older adults with obesity (DEMFOS trial): a randomised controlled trial
-
5
[Articles] Incidence of dementia after age 90 years and association with APOE genotype, race, and sex in the USA: the LifeAfter90 prospective cohort study
-
6
[Review] Effectiveness of dyadic interventions in improving outcomes for adults with multiple long-term conditions or frailty and their informal carers: a systematic review
-
7
[Comment] Statin discontinuation in older adults: changing the conversation, not the default
-
8
[Articles] Discontinuation of statins for primary prevention of atherosclerotic cardiovascular disease in adults aged 75 years or older (SAGA/SITE): a multicentre, open-label, pragmatic, non-inferiority randomised trial
-
9
[Comment] Revisiting relationships between APOE and dementia incidence in people aged 90 years and older
-
10
[Articles] Cognitive behavioural therapy for insomnia and epigenetic ageing: secondary analysis from a randomised controlled trial
The Lancet HIV
-
1
[Editorial] Will the new UN political declaration deliver?
-
2
[Correspondence] Occupational HIV monitoring should match standard of care
-
3
[Articles] Cost-effectiveness of emergency department opt-out testing for HIV in England: a modelling study
-
4
[Comment] Achieving 95-95-95 outcomes: it takes a couple
-
5
[Articles] Effectiveness of interventions to promote couples-based HIV testing and family health during pregnancy and postpartum in Kenya: a multicentre, couples-based, randomised controlled trial
-
6
[Comment] Invisible populations: SOGI data and HIV drug safety
-
7
[Articles] HIV acquisitions, safety, and pharmacokinetics of lenacapavir for HIV pre-exposure prophylaxis in pregnant and lactating women (PURPOSE 1): a substudy of a phase 3, randomised controlled trial
-
8
[Viewpoint] Does U=U apply during breastfeeding? An urgent research priority
-
9
[Articles] Interventions to improve viral suppression and adherence to antiretroviral therapy among people living with HIV: a systematic review and network meta-analysis
-
10
[Review] Evolving understanding of Kaposi sarcoma and associated diseases in the ART era
The Lancet Infectious Diseases
-
1
[Newsdesk] Research in brief
-
2
[Profile] Aalisha Sahukhan—strengthening public health responses
-
3
[Obituary] Clarence James Peters
-
4
[Editorial] Oral carbapenem—a double-edged sword?
-
5
[Clinical Picture] Tularaemia after deer exposure in a vehicular collision
-
6
[Correspondence] Seasonal influenza versus COVID-19 hospitalisation risk during the 2025–26 influenza season
-
7
[Correspondence] Diagnostic performance of RADIONE for diagnosis of BDBV
-
8
[Correspondence] Real-time epidemic intelligence in a public health emergency: the 2026 Bundibugyo virus outbreak
-
9
[Corrections] Correction to Lancet Infect Dis 2020; 20: 60–79
-
10
[Corrections] Correction to Lancet Infect Dis 2020; 20: 37–59
The Lancet Microbe
-
1
[Editorial] HIV, hepatitis, and STIs need renewed commitment
-
2
[Personal View] Project ODIN: advancing environmental genomic surveillance for public health across sub-Saharan Africa
-
3
[News] International response to hantavirus outbreak
-
4
[Correspondence] What constitutes a healthy vaginal microbiome? Implications for intervention strategies
-
5
[News] ESCMID Global Congress 2026
-
6
[Correspondence] Vaginal microbiota transplantation: from microbial transfer to ecological restoration
-
7
[Correspondence] Antiviral suppression and immune memory after nirmatrelvir–ritonavir
-
8
[Articles] Lineage-specific transmission and spatial clustering of Mycobacterium tuberculosis in Kaohsiung, Taiwan, in 2019–23: a population-based genomic study
-
9
[Comment] Hypervirulent Klebsiella pneumoniae K1-ST23 in Latin America: a neglected One Health threat
-
10
[Articles] Baseline Treg frequency, Treg-associated immune checkpoint responses, and plasma IL-10 responses during controlled human malaria infection in semi-immune Kenyan adults: a secondary analysis of the CHMI-SIKA Study
The Lancet Neurology
-
1
[Comment] Targeting orexin signalling in narcolepsy
-
2
[Articles] Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial
-
3
[Articles] Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysis
-
4
[Comment] Finding more intracranial aneurysms that will never rupture
-
5
[In Context] Adrian's alphabet of one
-
6
[Comment] Charting the future of biomarkers and therapy in Alzheimer's disease
-
7
[In Context] Third sector organisations unite to advance neuropalliative care
-
8
[Articles] Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
-
9
[Series] Fluid biomarkers in the evolving care landscape of Alzheimer's disease and related disorders
-
10
[In Context] Ancient brains in a modern world